Tatsis Ourania's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Aug 10, 2022
- Accession no.
- 0000899243-22-028248
- Filed
- Aug 10, 2022
- Trade date
- Aug 9, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $418.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tatsis OuraniaCIK 0001789815 | Officer (EVP, Chief Reg. & Quality Off.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2022 | Common Stock | SSaleDisposed | −292 | $297.54F3,F4 | −$86,881.68 | 47,198 | Direct | |
| Aug 9, 2022 | Common Stock | SSaleDisposed | −679 | $298.77F3,F5 | −$202,864.83 | 46,519 | Direct | |
| Aug 9, 2022 | Common Stock | SSaleDisposed | −283 | $299.79F3,F6 | −$84,840.57 | 46,236 | Direct | |
| Aug 9, 2022 | Common Stock | SSaleDisposed | −72 | $300.64 | −$21,646.08 | 46,164 | Direct | |
| Aug 9, 2022 | Common Stock | SSaleDisposed | −74 | $301.67 | −$22,323.58 | 46,090 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 3 transactions in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $297.54 (range $297.00 to $297.80).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $298.77 (range $298.29 to $299.19).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $299.79 (range $299.44 to $300.33).
Referenced by the price of 1 transaction in Table I.